Synthesis and SAR studies of a novel series of T-type calcium channel blockers.Bioorg Med Chem. 2006 May 15; 14(10):3502-11.BM
Abstract
For the novel, potent, and selective T-type Ca2+ channel blockers, a series of sulfonamido-containing 3,4-dihydroquinazoline derivatives were prepared and evaluated for their blocking actions on T- and N-type Ca2+ channels. Among them, 9c (KYS05064, IC50 = 0.96 +/- 0.22 microM) was found to be as potent as Mibefradil and also showed the highest selectivity for T-type Ca2+ channel with no effect on N-type Ca2+ channel.
MeSH
Pub Type(s)
Journal Article
Research Support, Non-U.S. Gov't
Language
eng
PubMed ID
16434203
Citation
Park, Seong Jun, et al. "Synthesis and SAR Studies of a Novel Series of T-type Calcium Channel Blockers." Bioorganic & Medicinal Chemistry, vol. 14, no. 10, 2006, pp. 3502-11.
Park SJ, Park SJ, Lee MJ, et al. Synthesis and SAR studies of a novel series of T-type calcium channel blockers. Bioorg Med Chem. 2006;14(10):3502-11.
Park, S. J., Park, S. J., Lee, M. J., Rhim, H., Kim, Y., Lee, J. H., Chung, B. Y., & Lee, J. Y. (2006). Synthesis and SAR studies of a novel series of T-type calcium channel blockers. Bioorganic & Medicinal Chemistry, 14(10), 3502-11.
Park SJ, et al. Synthesis and SAR Studies of a Novel Series of T-type Calcium Channel Blockers. Bioorg Med Chem. 2006 May 15;14(10):3502-11. PubMed PMID: 16434203.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - Synthesis and SAR studies of a novel series of T-type calcium channel blockers.
AU - Park,Seong Jun,
AU - Park,Sung Jun,
AU - Lee,Min Joo,
AU - Rhim,Hyewhon,
AU - Kim,Yoonjee,
AU - Lee,Jung-Ha,
AU - Chung,Bong Young,
AU - Lee,Jae Yeol,
Y1 - 2006/01/24/
PY - 2005/12/12/received
PY - 2005/12/30/revised
PY - 2006/01/04/accepted
PY - 2006/1/26/pubmed
PY - 2006/8/9/medline
PY - 2006/1/26/entrez
SP - 3502
EP - 11
JF - Bioorganic & medicinal chemistry
JO - Bioorg Med Chem
VL - 14
IS - 10
N2 - For the novel, potent, and selective T-type Ca2+ channel blockers, a series of sulfonamido-containing 3,4-dihydroquinazoline derivatives were prepared and evaluated for their blocking actions on T- and N-type Ca2+ channels. Among them, 9c (KYS05064, IC50 = 0.96 +/- 0.22 microM) was found to be as potent as Mibefradil and also showed the highest selectivity for T-type Ca2+ channel with no effect on N-type Ca2+ channel.
SN - 0968-0896
UR - https://www.unboundmedicine.com/medline/citation/16434203/Synthesis_and_SAR_studies_of_a_novel_series_of_T_type_calcium_channel_blockers_
DB - PRIME
DP - Unbound Medicine
ER -